title: Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.
abstract: Adeno-associated viruses (AAVs) currently are being developed to efficiently transduce the retina following noninvasive, intravitreal (Ivt) injection. However, a major barrier encountered by intravitreally delivered AAVs is the inner limiting membrane (ILM), a basement membrane rich in heparan sulfate (HS) proteoglycan. The goal of this study was to determine the impact of HS binding on retinal transduction by Ivt-delivered AAVs. The heparin affinities of AAV2-based tyrosine-to-phenylalanine (Y-F) and threonine-to-valine (T-V) capsid mutants, designed to avoid proteasomal degradation during cellular trafficking, were established. In addition, the impact of grafting HS binding residues onto AAV1, AAV5, and AAV8(Y733F) as well as ablation of HS binding by AAV2-based vectors on retinal transduction was investigated. Finally, the potential relationship between thermal stability of AAV2-based capsids and Ivt-mediated transduction was explored. The results show that the Y-F and T-V AAV2 capsid mutants bind heparin but with slightly reduced affinity relative to that of AAV2. The grafting of HS binding increased Ivt transduction by AAV1 but not by AAV5 or AAV8(Y733F). The substitution of any canonical HS binding residues ablated Ivt-mediated transduction by AAV2-based vectors. However, these same HS variant vectors displayed efficient retinal transduction when delivered subretinally. Notably, a variant devoid of canonical HS binding residues, AAV2(4pMut)ΔHS, was remarkably efficient at transducing photoreceptors. The disparate AAV phenotypes indicate that HS binding, while critical for AAV2-based vectors, is not the sole determinant for transduction via the Ivt route. Finally, Y-F and T-V mutations alter capsid stability, with a potential relationship existing between stability and improvements in retinal transduction by Ivt injection.
  
  
  OBJECTIVE
  AAV has emerged as the vector of choice for gene delivery to the retina, with attention focused on developing vectors that can mediate transduction following noninvasive, intravitreal injection. HS binding has been postulated to play a role in intravitreally mediated transduction of retina. Our evaluation of the HS binding of AAV2-based variants and other AAV serotype vectors and the correlation of this property with transduction points to HS affinity as a factor controlling retinal transduction following Ivt delivery. However, HS binding is not the only requirement for improved Ivt-mediated transduction. We show that AAV2-based vectors lacking heparin binding transduce retina by subretinal injection and display a remarkable ability to transduce photoreceptors, indicating that other receptors are involved in this phenotype.
authors: Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA.
authors: Sanford L
authors: SL
authors: Boye
authors: Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida, USA.
authors: Antonette
authors: A
authors: Bennett
authors: Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA.
authors: Miranda L
authors: ML
authors: Scalabrino
authors: Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA.
authors: K Tyler
authors: KT
authors: McCullough
authors: Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida, USA.
authors: Kim
authors: K
authors: Van Vliet
authors: Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA.
authors: Shreyasi
authors: S
authors: Choudhury
authors: Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA.
authors: Qing
authors: Q
authors: Ruan
authors: Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA.
authors: James
authors: J
authors: Peterson
authors: Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida, USA mckenna@ufl.edu Shannon.Boye@eye.ufl.edu.
authors: Mavis
authors: M
authors: Agbandje-McKenna
authors: Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA mckenna@ufl.edu Shannon.Boye@eye.ufl.edu.
authors: Shannon E
authors: SE
authors: Boye
mesh_terms: D000818:Animals; D002213:Capsid / Q000378:metabolism; D000229:Dependovirus / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D005822:Genetic Vectors / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D057809:HEK293 Cells; D006497:Heparan Sulfate / Q000494:pharmacology*; D006801:Humans; D056965:Injections, Intraocular; D007275:Injections, Intravenous; D008099:Liver / Q000378:metabolism; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009154:Mutation; D020419:Photoreceptor Cells, Vertebrate / Q000378:metabolism; D016865:Reassortant Viruses / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D012160:Retina / Q000378:metabolism*; D014161:Transduction, Genetic; D014822:Vitreous Body / Q000378:metabolism
chemical_list: D006497:Heparan Sulfate